Some people are going to hate this. But the truth is, some AI projects in the Philippines are scam – they just want to get funded. They could be somewhere right under your nose the whole time. Real science makes real impact, and the launch of Covary is a proof that ChordexBio delivers beyond funding requirements.

"Innovation is not measured by announcements or funding alone; it is measured by tangible, reproducible contributions that push boundaries forward." ⸺ Marvin De los Santos, ChordexBio Lead

In the Philippines, many AI and machine learning efforts have been proposed and celebrated, yet few have translated into sustained, working systems in genomic science. Covary is changing that narrative. Developed by ChordexBio — algorithms empowering lives, Covary is the Philippines' first genomic intelligence research program built not around hype, but real capability, real outcomes, and real scientific contribution.

Covary is not another conceptual project or a series of disconnected experiments. It is an operational genomic intelligence infrastructure that enables Filipino researchers to explore, analyze, and contribute to complex genomic problems using machine learning, evolutionary models, and computational biology techniques.

"Covary is here, now. Ready to make real impact." ⸺ Marvin De los Santos, ChordexBio Lead

The architecture and workflows of Covary are designed to translate complex genomic data into actionable insights, enabling researchers to work on real problems, not just theoretical ones.

The gap

In the Philippine research environment, access to advanced genomic analytics and machine learning workflows is limited. Many institutions lack the computational tools needed to engage with data-driven life sciences at scale. This limits the ability of Filipino scientists to contribute to global genomic research conversations and slows local scientific progress.

Covary addresses this gap by providing:

1. A structured research framework for genomic intelligence analysis

2. Machine learning models optimized for genomic data

3. Collaborative pathways that allow Filipino researchers to contribute meaningfully

4. A platform grounded in reproducibility and impact readiness

Through this infrastructure, Covary empowers researchers to move beyond data interpretation toward discovery and innovation.

--- page break ---

Why this matters now

Genomic intelligence, which is the intersection of genomics, computational models, and machine learning is reshaping our understanding of biology, disease, and evolution. Globally, institutions with access to this capability are making breakthroughs in areas like cancer evolution, population genetics, and pathogen surveillance.

Covary positions Filipino researchers to participate in these frontiers with tools and systems that are built for purpose, not flair.

The best part is we've created the Covary Research Program (CRP) to reach researchers who are deeply passionate about advancing genomic intelligence, but who may lack access to the infrastructure needed to do meaningful work. The CRP exists to connect that passion with real systems, real problems, and real scientific contribution.

Looking ahead

The development of Covary marks a foundational step toward building a resilient genomic research ecosystem in the Philippines. But this is just the beginning. We envision a future where Filipino scientists: 1) lead data-driven genomic discovery; 2) engage with global research communities; 3) contribute research outputs with national and international impact. For this vision to thrive, we need researchers who are ready to engage, contribute, and deliver.

"So, if someone asked what's our impact? We say, to make genomic intelligence accessible, actionable, and Filipino-led , and to build a community that delivers real science". ⸺ Marvin De los Santos, ChordexBio Lead

If you are passionate about advancing genomic intelligence and want to be part of a research effort that produces not just promises, ChordexBio is the right place for you.

We value your feedback, tell us what you think. Contact us

Related stories: